Pelzman's Picks: Do Rich People Get More Mental Health Meds?

<乌鸦传媒 class="mpt-content-deck">— Also, many generic drugs aren't available in the U.S.

by Fred Pelzman, MD, February 12, 2019

Fred Pelzman is an associate professor of medicine at Weill Cornell, and has been a practicing internist for nearly 30 years. He is medical director of Weill Cornell Internal Medicine Associates.

A recent analysis revealed that wealthier individuals are purchasing more prescription drugs to treat mental disorders and other serious conditions than their less wealthy peers, write Kevin Quealy and Margot Sanger-Katz ~ (New York Times)
"A new world of pain treatment is on the horizon," writes Laura Landro who explores recent advances in measuring, understanding, and treating pain ~ (The Wall Street Journal)
Mark R. Katlic, MD, and colleagues explore strategies to determine how well older surgeons are performing ~ (JAMA)
Almost half of recently approved generic drugs are not available in the U.S., write Sydney Lupkin and Jay Hancock ~ (Kaiser Health News)
Richard B. Weinberg, MD, reflects on managing a physician who was "susceptible to bouts of dark pessimism" ~ (Annals of Internal Medicine)
Peter A. Ubel, MD, and Meredith B. Rosenthal, PhD, discuss what it will take to make healthcare better ~ When Improving Health Calls for Greater Assertiveness (New England Journal of Medicine)
"I briefly believed that outing myself as a person with a disability was enough, but quickly realized that the barriers for faculty members with disabilities surpass personal acceptance," writes Bonnielin Swenor, PhD, MPH, reflecting on the challenges of managing a disability ~ (JAMA)

, of Weill Cornell Internal Medicine Associates and , follows what's going on in the world of primary care medicine. Pelzman's Picks is a compilation of links to blogs, articles, tweets, journal studies, opinion pieces, and news briefs related to primary care that caught his eye.